|
🦁
|
Structural and Functional Aspects of RGD-Containing Cyclic Pentapeptides as Highly Potent and Selective Integrin αVβ3 Antagonists
R. Haubner,
R. Gratias,
B. Diefenbach,
S. Goodman,
A. Jończyk*,
H. Kessler
|
9 |
1996 |
9
🦁
|
|
🦁
|
Noninvasive Imaging of αvβ3 Integrin Expression Using 18F-labeled RGD-containing Glycopeptide and Positron Emission Tomography
9 auth.
R. Haubner,
H. Wester,
W. Weber,
C. Mang,
S. Ziegler,
S. Goodman,
...
R. Senekowitsch-Schmidtke,
H. Kessler,
M. Schwaiger
|
9 |
2001 |
9
🦁
|
|
🦁
|
Noninvasive Visualization of the Activated αvβ3 Integrin in Cancer Patients by Positron Emission Tomography and [18F]Galacto-RGD
12 auth.
R. Haubner,
W. Weber,
A. Beer,
E. Vabuliene,
D. Reim,
M. Sarbia,
...
K. Becker,
Michael Goebel,
R. Hein,
H. Wester,
H. Kessler,
M. Schwaiger
|
8 |
2005 |
8
🦁
|
|
🦁
|
Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics.
8 auth.
R. Haubner,
Hans-Juergen Wester,
F. Burkhart,
R. Senekowitsch-Schmidtke,
Wolfgang A. Weber,
Simon L. Goodman,
...
Horst Kessler,
Markus Schwaiger
|
8 |
2001 |
8
🦁
|
|
🦁
|
Stereoisomeric Peptide Libraries and Peptidomimetics for Designing Selective Inhibitors of the αvβ3 Integrin for a New Cancer Therapy
R. Haubner,
Dipl.-Chem. Dirk Finsinger,
H. Kessler
|
8 |
1997 |
8
🦁
|
|
🦁
|
Radiolabeled αvβ3 Integrin Antagonists: A New Class of Tracers for Tumor Targeting
8 auth.
R. Haubner,
H. Wester,
U. Reuning,
R. Senekowitsch-Schmidtke,
B. Diefenbach,
H. Kessler,
...
G. Stöcklin,
M. Schwaiger
|
8 |
1999 |
8
🦁
|
|
🦁
|
[18F]Galacto-RGD: synthesis, radiolabeling, metabolic stability, and radiation dose estimates.
7 auth.
R. Haubner,
B. Kuhnast,
C. Mang,
W. Weber,
H. Kessler,
H. Wester,
...
M. Schwaiger
|
8 |
2004 |
8
🦁
|
|
🐜
|
TNFR1 signaling and IFN-gamma signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis.
17 auth.
Nele Müller-Hermelink,
H. Braumüller,
B. Pichler,
T. Wieder,
R. Mailhammer,
K. Schaak,
K. Ghoreschi,
A. Yazdi,
R. Haubner,
C. Sander,
...
R. Mocikat,
M. Schwaiger,
I. Förster,
R. Huss,
W. Weber,
M. Kneilling,
M. Röcken
|
8 |
2008 |
8
🐜
|
|
🐜
|
Positron Emission Tomography Using [18F]Galacto-RGD Identifies the Level of Integrin αvβ3 Expression in Man
12 auth.
A. Beer,
R. Haubner,
M. Sarbia,
Michael Goebel,
S. Luderschmidt,
A. Grosu,
...
O. Schnell,
M. Niemeyer,
H. Kessler,
H. Wester,
W. Weber,
M. Schwaiger
|
8 |
2006 |
8
🐜
|
|
🐜
|
Biodistribution and pharmacokinetics of the alphavbeta3-selective tracer 18F-galacto-RGD in cancer patients.
8 auth.
A. Beer,
R. Haubner,
Michael Goebel,
S. Luderschmidt,
M. Spilker,
H. Wester,
...
W. Weber,
M. Schwaiger
|
8 |
2005 |
8
🐜
|
|
🐜
|
[18F]Galacto-RGD Positron Emission Tomography for Imaging of αvβ3 Expression on the Neovasculature in Patients with Squamous Cell Carcinoma of the Head and Neck
10 auth.
A. Beer,
A. Grosu,
J. Carlsen,
A. Kolk,
M. Sarbia,
I. Stangier,
...
P. Watzlowik,
H. Wester,
R. Haubner,
M. Schwaiger
|
7 |
2007 |
7
🐜
|
|
🐜
|
Imaging of integrin alpha(v)beta(3) expression in patients with malignant glioma by [18F] Galacto-RGD positron emission tomography.
15 auth.
O. Schnell,
B. Krebs,
J. Carlsen,
I. Miederer,
C. Goetz,
R. Goldbrunner,
H. Wester,
R. Haubner,
G. Pöpperl,
M. Holtmannspötter,
...
H. Kretzschmar,
H. Kessler,
J. Tonn,
M. Schwaiger,
A. Beer
|
7 |
2009 |
7
🐜
|
